Skip to main navigation

Client Header Links

  • About
    • Board of Directors
    • Founders
    • Leadership
    • Scientific Advisors
  • Platform
    • Technology Overview
    • Publications
  • Pipeline
    • Pipeline Overview
    • ANX005
    • ANX007
  • Investors
    • Overview
    • News Releases
    • Events and Presentations
    • Corporate Governance
    • Stock Information
    • SEC Filings
    • Shareholder Services
  • Careers
  • Contact
  • Annexon
    Biosciences

SEC Filing Details

Investor Relations

Home
Corporate Profile
News Releases
Corporate Governance
Governance Overview
Board of Directors
Leadership
Committee Composition
SEC Filings
Contact IR

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 16, 2020
Document Date
Sep 30, 2020
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Annexon Inc.
Issuer
Annexon, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

Investor Tools

  • Print
    Print
  • IR Contact
    IR Contact
  • RSS Feeds
    RSS Feeds
  • Email Alerts
    Email Alerts

Quick Links

Quick links

  • Pipeline
  • Platform
  • About
  • Careers
  • Privacy Policy
  • Terms of Use

stop the start of disease

Annexon Biosciences is a clinical-stage biopharmaceutical company developing novel therapies for autoimmune and neurodegenerative diseases, including opthalmic diseases.

Annexon
Biosciences

Social Media

Copyright © 2016 - 2021 Annexon Inc..
All rights reserved.